Wednesday, December 25, 2024
HomeTagsChina

China

MIOK Keratoprosthesis, the World’s First Artificial Cornea gets Chinese approval

On December 7, 2021, MIOK Keratoprosthesis was approved for listing by NMPA, the Chinese agency for regulating drugs and medical devices. MIOK Keratoprosthesis is...

Peijia Medical is Licensed for JenaValve’s Trilogy TAVR System

Peijia Medical Limited is pleased to announce its strategic investment and exclusive in-licensing agreement with JenaValve Technology, Inc. Under the terms of the agreement,...

Review in Chinese Medical Journal Explores Effect of Gut Microbiota on Inflammatory Bowel Disease

The human gut is inhabited by a plethora of micro-organisms, collectively called the "microbiota," which are important for normal physiological processes. "Dysbiosis" or an...

ImmVira’s MVR-T3011 IV completed first 2 cohorts dose-escalation of U.S. Phase I clinical study with favorable safety data

ImmVira's breakthrough product MVR-T3011 IV, global first clinical-stage oncolytic herpes simplex virus (oHSV) via intravenous injection, has recently completed first 2 cohorts dose-escalation of...

CANbridge Pharmaceuticals CAN108 New Drug Application (NDA) for Alagille Syndrome Accepted by China’s National Medical Products Administration

CANbridge Pharmaceuticals Inc., (“CANbridge,” stock code 1228.HK) a leading China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics